Lotriderm

How to order Lotriderm

1. Find the drug you need on our site.
2. Pick a clinic. See the price.
3. Fill in a short health form.
4. A doctor reads your form.
5. If it is safe for you, they say yes.
6. Your order ships fast to your door.
7. It comes in a plain, sealed box.

Why use us? We compare UK clinics. We show you the price and how fast they ship. We do not sell drugs. We just help you find the best one for you.

Is it safe? Yes. All our clinics are UK-based. A real doctor reads each form. They will not sell to you if it is not safe for you.

Lotriderm on Prescriptsy

Lotriderm is described on Prescriptsy as independent product information.

Here you can understand how online consultation works, what medical checks partner clinics carry out, and which factors matter when comparing providers.

We do not sell medicines directly, but help users compare licensed healthcare partners on price, delivery speed, service quality, and overall trustworthiness.

Lotriderm is a prescription-only topical cream used in the United Kingdom for the treatment of fungal skin infections complicated by inflammation.

It contains two active ingredients: clotrimazole 1%, a broad-spectrum imidazole antifungal, and betamethasone dipropionate 0.05%, a potent (Group III) topical corticosteroid.

This dual-action formulation addresses both the underlying fungal infection and the associated inflammatory symptoms of redness, itching, swelling, and discomfort, providing faster symptomatic relief than an antifungal agent alone.

Fungal skin infections are extremely common in the UK, affecting millions of people each year.

Dermatophyte infections (tinea) and superficial candidal infections can cause significant itching, redness, cracking, and scaling of the skin, particularly in warm and moist areas such as the feet, groin, and skin folds.

When the inflammatory component is prominent, a combination product such as Lotriderm may be prescribed for an initial short course to bring symptoms under control rapidly, before stepping down to a plain antifungal to complete eradication of the infection.

This page provides a comprehensive clinical overview of Lotriderm, including how it works, correct application, dosing guidance, side effects, safety warnings, and how to obtain a prescription in the UK.

Important safety information about Lotriderm

Before reading further, note the following key safety points about Lotriderm.

• Lotriderm contains a potent corticosteroid. It should be used for the shortest effective duration and should not be applied continuously for more than 4 weeks without medical review.
• Do not apply Lotriderm to the face for more than 5 days, or to the groin or armpits for more than 7 days, unless directed by your prescriber.
• Do not use Lotriderm for conditions it is not prescribed for, including acne, rosacea, eczema (unless also fungally infected and prescribed by a doctor), or viral skin infections.
• Lotriderm should not be used under occlusive dressings unless specifically instructed, as this increases the absorption of the corticosteroid.

What are fungal skin infections

Fungal skin infections are caused by microscopic organisms that live on the outer layer of the skin (stratum corneum), nails, and hair.

The most common causative agents are dermatophytes (fungi of the genera Trichophyton, Microsporum, and Epidermophyton) and yeasts (primarily Candida albicans and Malassezia species).

Dermatophytes thrive in warm, moist environments and obtain nutrients by breaking down keratin, the protein that forms the structural framework of the skin, hair, and nails.

The clinical presentation of fungal skin infections varies depending on the site and the causative organism.

Tinea pedis (athlete's foot) presents as itchy, peeling, cracked, or macerated skin between the toes or on the soles.

Tinea cruris (jock itch) causes a red, itchy rash in the groin creases, often spreading to the inner thighs.

Tinea corporis (ringworm) produces characteristic annular (ring-shaped) patches with a raised, scaly, erythematous border and central clearing.

Candidal intertrigo occurs in skin folds (such as under the breasts, in the groin, or in the axillae) and presents as bright red, moist, macerated patches, often with satellite lesions (small red spots surrounding the main area).

While many uncomplicated fungal infections respond well to plain antifungal creams (such as clotrimazole, miconazole, or terbinafine), some infections present with significant inflammatory features including intense redness, swelling, vesiculation (blistering), and severe pruritus (itching).

In these cases, the addition of a corticosteroid provides rapid symptomatic relief while the antifungal agent begins to eradicate the underlying infection.

How Lotriderm works: mechanism of action

Clotrimazole (antifungal component)

Clotrimazole is a synthetic imidazole antifungal that acts by inhibiting the enzyme lanosterol 14-alpha-demethylase, a cytochrome P450-dependent enzyme essential for the conversion of lanosterol to ergosterol.

Ergosterol is a critical structural component of the fungal cell membrane, analogous to cholesterol in mammalian cell membranes.

When ergosterol synthesis is blocked, the fungal cell membrane becomes increasingly permeable, leading to leakage of intracellular potassium and other essential metabolites, disruption of membrane-bound enzyme function, and ultimately fungal cell death.

Clotrimazole has broad-spectrum antifungal activity against dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum canis, Epidermophyton floccosum), Candida species (including C. albicans and C.

glabrata), Malassezia furfur, and some Gram-positive bacteria.

It is poorly absorbed through intact skin, which confines its action to the superficial layers of the epidermis where dermatophytes and superficial yeasts reside.

Betamethasone dipropionate (corticosteroid component)

Betamethasone dipropionate is classified as a potent (Group III in the UK four-group potency classification) topical corticosteroid.

It exerts its anti-inflammatory effects by binding to intracellular glucocorticoid receptors in keratinocytes, Langerhans cells, and dermal fibroblasts.

The activated receptor complex translocates to the nucleus and modulates gene transcription, leading to suppression of pro-inflammatory mediators including prostaglandins, leukotrienes, cytokines (IL-1, IL-6, TNF-alpha), and adhesion molecules.

This results in reduced capillary permeability (decreasing redness and swelling), suppression of inflammatory cell migration (reducing the inflammatory infiltrate), decreased keratinocyte proliferation, and potent anti-pruritic effects.

The combined action of clotrimazole and betamethasone dipropionate provides simultaneous antifungal and anti-inflammatory effects, which is why Lotriderm is more effective than either component alone for the initial treatment of inflamed fungal dermatoses.

However, because betamethasone is a potent corticosteroid, its use should be time-limited to minimise the risk of local and systemic side effects.

Clinical evidence and national guidelines

The combination of clotrimazole and betamethasone dipropionate has been studied in multiple randomised controlled trials.

These studies consistently demonstrate that the combination provides faster relief of inflammatory symptoms (redness, itching, and swelling) compared with clotrimazole alone, while achieving equivalent or superior mycological cure rates when used for the recommended duration.

The BNF (British National Formulary) lists clotrimazole/betamethasone combination products under topical antifungal preparations and notes that they are suitable for inflamed dermatophyte and candidal infections where significant inflammation is present.

The BNF advises that the potent corticosteroid component should be used for the shortest possible duration to control inflammation, after which treatment should be stepped down to a plain antifungal cream.

NICE Clinical Knowledge Summaries (CKS) on dermatophyte infections recommend topical antifungals as first-line treatment for localised tinea infections.

When inflammation is marked, a combined antifungal-corticosteroid preparation such as Lotriderm may be used for an initial period of up to 2 weeks, followed by a plain antifungal.

Prolonged use of topical corticosteroids on fungal infections is discouraged, as it can promote fungal spread and mask clinical signs of persistent infection (tinea incognito).

Dosage and administration

Lotriderm cream should be applied thinly and evenly to the affected area and the immediately surrounding skin twice daily, in the morning and evening.

Gently rub the cream into the skin until it is no longer visible. Wash your hands before and after application, unless the hands are the area being treated.

Treatment duration by condition

For tinea cruris (jock itch) and tinea corporis (ringworm), the recommended treatment duration is 2 weeks.

For tinea pedis (athlete's foot), the duration is up to 4 weeks, as dermatophyte infection of the feet often involves thicker skin (the plantar surface) that requires a longer treatment course for complete eradication.

Treatment should not exceed 4 weeks without medical review.

Step-down approach

Once the inflammatory component has resolved (typically within 3 to 7 days), your prescriber may recommend switching to a plain antifungal cream such as clotrimazole 1% (available over the counter) or terbinafine 1% to complete the full treatment course.

This strategy minimises exposure to the potent corticosteroid while ensuring the fungal infection is fully eradicated.

Premature discontinuation of antifungal treatment, even after symptoms resolve, increases the risk of relapse.

Areas requiring special caution

The face, groin, axillae, and other flexural areas have thinner skin and greater corticosteroid absorption.

Lotriderm should not be applied to the face for more than 5 days, or to the groin and axillae for more than 7 days, without medical supervision.

Do not apply Lotriderm under occlusive dressings (bandages, cling film, or tight non-breathable clothing) as occlusion increases corticosteroid penetration and the risk of atrophy and systemic effects.

In children, nappies may act as occlusive dressings, so use with particular caution in the nappy area.

Side effects of Lotriderm

Local side effects

The most commonly reported side effects are local reactions at the application site, including mild burning, stinging, or itching immediately after application. These are usually transient and resolve within minutes.

Corticosteroid-related local effects

With prolonged or inappropriate use of the betamethasone component, the following local side effects may develop: skin thinning (atrophy), which may manifest as shiny, fragile skin with visible underlying blood vessels; stretch marks (striae), which are often permanent; telangiectasia (dilated superficial blood vessels); easy bruising (purpura); folliculitis (infection of hair follicles); hypertrichosis (increased hair growth at the application site); hypopigmentation (lightening of the skin colour); and perioral dermatitis or rosacea-like changes if applied to the face.

These effects are largely preventable by adhering to the recommended treatment duration and avoiding application to areas of thin skin.

Tinea incognito

The corticosteroid component can modify the clinical appearance of a fungal infection, making it appear to improve while the infection continues to spread beneath the surface.

This phenomenon is known as tinea incognito.

The rash loses its characteristic annular border and scaling, making diagnosis more difficult and potentially leading to a larger, more extensive infection that is harder to treat.

This is a key reason why Lotriderm should be used for a limited duration and the diagnosis should be reconsidered if the infection does not respond as expected.

Systemic side effects

Systemic absorption of betamethasone is minimal when Lotriderm is used as directed for short courses on limited skin areas.

However, significant systemic absorption can occur with prolonged use, application to large body surface areas, use under occlusion, or application to broken skin.

In rare cases, this may result in hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing syndrome features, hyperglycaemia, and glycosuria.

Children are at particular risk due to their higher surface area to body weight ratio.

Reporting side effects

Report any suspected adverse reactions to your prescriber or directly via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Warnings and precautions

Not for unsupervised use

Lotriderm contains a potent corticosteroid and should be used only under medical supervision.

Do not share the cream with others, do not use it for conditions other than those diagnosed by your prescriber, and do not continue use beyond the prescribed duration without review.

The potent steroid component means Lotriderm is not a substitute for standard antifungal creams available over the counter.

Avoid on certain skin conditions

Do not apply Lotriderm to primary bacterial skin infections (impetigo, cellulitis), viral skin conditions (herpes simplex, chickenpox, shingles, warts), acne vulgaris, rosacea, perioral dermatitis, or untreated secondary skin infections.

The corticosteroid component can mask or worsen these conditions, leading to diagnostic delay and disease progression.

Pregnancy and breastfeeding

The safety of topical betamethasone dipropionate during pregnancy has not been fully established.

Animal studies have shown that corticosteroids can cause fetal abnormalities when applied in large amounts or under occlusion.

Although topical application in humans at recommended doses is unlikely to produce significant systemic levels, potent topical corticosteroids should be avoided during pregnancy unless the benefit clearly outweighs the risk.

If treatment is necessary, use the smallest amount for the shortest duration. During breastfeeding, do not apply Lotriderm to the breasts. Discuss alternatives with your prescriber or midwife.

Secondary infection

If a secondary bacterial infection develops at the site of a fungal infection being treated with Lotriderm, the corticosteroid component may mask the signs of bacterial infection, allowing it to progress.

If the treated area becomes more painful, hot, swollen, or develops pus or crusting, stop using the cream and consult your prescriber. Appropriate antibacterial treatment may be required.

How to get a Lotriderm prescription in the UK

Lotriderm is a prescription-only medicine (POM) in the UK.

It can be prescribed by your GP following a clinical assessment that may include visual examination and, where appropriate, skin scrapings for mycological testing to confirm the fungal diagnosis.

An authorised online prescriber registered with the GPhC can also prescribe Lotriderm following a suitable clinical consultation.

Plain clotrimazole cream (without steroid) is available over the counter from pharmacies as a General Sales List (GSL) or pharmacy-only (P) medicine for uncomplicated fungal infections.

If your fungal infection is not significantly inflamed, your pharmacist may recommend clotrimazole, miconazole, or terbinafine cream as a first-line over-the-counter treatment.

The standard NHS prescription charge in England is currently 9.90 pounds per item; prescriptions are free in Scotland, Wales, and Northern Ireland.

Preventing fungal skin infections

Fungal skin infections are often recurrent, particularly in individuals with predisposing factors. The following measures can reduce the risk of reinfection.

• Keep the skin clean and dry, particularly in warm, moist areas such as between the toes, the groin, and under the breasts.
• Dry thoroughly after bathing or showering, paying attention to skin folds and toe web spaces.
• Wear loose-fitting, breathable clothing and underwear made from natural fibres such as cotton.
• Change socks and underwear daily, and more frequently after exercise or heavy sweating.
• Wear flip-flops or sandals in communal changing rooms, showers, and swimming pool areas.
• Do not share towels, clothing, or footwear with others.
• Treat any concurrent fungal nail infection, as this can serve as a reservoir for recurrent skin infection.
• Manage underlying conditions such as diabetes and obesity that predispose to fungal infections.

When to seek medical advice

Contact your GP or NHS 111 if your fungal infection does not improve within 1 week of starting Lotriderm, if symptoms worsen, or if the rash spreads significantly despite treatment.

Lack of improvement may indicate a misdiagnosis, a resistant organism, or the development of tinea incognito.

Seek urgent medical advice if you develop signs of a severe allergic reaction (widespread rash, facial swelling, breathing difficulty), signs of a secondary bacterial infection (increasing pain, warmth, swelling, pus), or signs of adrenal suppression after prolonged use (fatigue, dizziness, nausea).

Report suspected adverse reactions via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk .

Sources

• Lotriderm Cream, Summary of Product Characteristics (EMC)
• Betamethasone with clotrimazole, British National Formulary (BNF)
• Fungal skin infection, body and groin, NICE CKS
• Fungal skin infection, foot, NICE CKS
• Athlete's foot, NHS
• MHRA Yellow Card Scheme